Literature DB >> 7317402

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells.

S A Murphree, T R Tritton, P L Smith, A C Sartorelli.   

Abstract

Adriamycin increases (a) the rate of agglutination of Sarcoma 180 cells by concanavalin A after brief exposure of 2-3 h and (b) membrane fluidity as measured by ESR within 30 min of exposure at concentrations of the anthracycline of 10(-7)-10(-5) M. The effect of adriamycin on agglutination is not due to an increase in the number of surface receptors for concanavalin A, since the extent of binding of the lectin is not altered by adriamycin and no change occurs in the rate of occupancy of the concanavalin A binding sites by the lectin in cells treated with the antibiotic. The order parameter, a measurement of membrane fluidity, decreases in cells exposed to adriamycin and is dose-related. The results indicate that adriamycin can induce changes in the surface membrane of Sarcoma 180 cells within a brief period of exposure to a low but cytotoxic level of this agent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317402     DOI: 10.1016/0005-2736(81)90421-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Cardiotoxic effects of anthracyclines.

Authors:  M R Bristow
Journal:  West J Med       Date:  1983-09

Review 2.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

3.  Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.

Authors:  M A Alaoui Jamali; M B Yin; A Mazzoni; I Bankusli; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Inhibitory effects of anthracyclines on partially purified 5'-3' DNA helicase of Plasmodium falciparum.

Authors:  Pongruj Rattaprasert; Pattra Suntornthiticharoen; Paviga Limudomporn; Kanthinich Thima; Porntip Chavalitshewinkoon-Petmitr
Journal:  Malar J       Date:  2022-07-11       Impact factor: 3.469

5.  Adriamycin inhibits PTH-mediated but not PGE2-mediated stimulation of cyclic AMP formation in isolated bone cells.

Authors:  G Kohler; V Shen; W A Peck
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

6.  In vivo effects of doxorubicin on kinase C in cultured cells.

Authors:  M Otsuka; H Shigeoka; H C Yang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Changes of membrane fluidity and Na+,K+-ATPase activity during cellular differentiation in the guinea pig epidermis.

Authors:  T Tanaka; T Hidaka; R Ogura; M Sugiyama
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

8.  Adriamycin-induced inhibition of melanoma cell invasion is correlated with decreases in tumor cell motility and increases in focal contact formation.

Authors:  L A Repesh; S R Drake; M C Warner; S W Downing; R Jyring; E A Seftor; M J Hendrix; J B McCarthy
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

9.  Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma.

Authors:  Burhan Savas; Pauline E Kerr; Hugh F Pross
Journal:  Cancer Cell Int       Date:  2006-11-03       Impact factor: 5.722

10.  Anthracycline-induced inhibition of membrane permeability functions dependent on metabolic energy.

Authors:  A C Croce; E Prosperi; R Supino; G Bottiroli
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.